// App-Quantinova.ai

: Impact of Prolonged Venous Thromboembolism Prophylaxis on 30-Day Hemostatic Outcomes Following Kidney Transplantation in Patients with Hypercoagulable Risk Factors

Researchers

Presenter

  • V. Behbahani

Principal Investigators

  • A. Santeusanio

  • S. Ames

  • R. Shapiro

Medical Centers

  • Mount Sinai Hospital, New York, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

  • Autoimmune (AI)

  • Gastroenterology (GU)

Disease

  • Antiphospholipid syndrome

  • Venous thrombosis

  • Cirrhosis

Biomarkers

  • N/A

Drug/Treatment

  • FVIII

  • Hemostatic Solution

  • Protein C

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved